000844289 001__ 844289
000844289 005__ 20210129232850.0
000844289 0247_ $$2doi$$a10.1007/s40336-017-0242-y
000844289 0247_ $$2ISSN$$a2281-5872
000844289 0247_ $$2ISSN$$a2281-7565
000844289 0247_ $$2WOS$$aWOS:000411570700006
000844289 0247_ $$2altmetric$$aaltmetric:24461802
000844289 037__ $$aFZJ-2018-01729
000844289 082__ $$a610
000844289 1001_ $$00000-0003-2850-9450$$aHammes, Jochen$$b0$$eCorresponding author
000844289 245__ $$aMolecular imaging in early diagnosis, differential diagnosis and follow-up of patients with neurodegenerative diseases
000844289 260__ $$aBerlin$$bSpringer Milan$$c2017
000844289 3367_ $$2DRIVER$$aarticle
000844289 3367_ $$2DataCite$$aOutput Types/Journal article
000844289 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1520521453_23726
000844289 3367_ $$2BibTeX$$aARTICLE
000844289 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000844289 3367_ $$00$$2EndNote$$aJournal Article
000844289 520__ $$aPurposeCurrent disease models suggest that many neurodegenerative disorders are associated with pathological protein aggregations that start to develop in the brain long before the onset of clinical symptoms. Therefore, biomarkers allowing early and reliable characterization of neurodegenerative disease are required. Here we illustrate the potential value of neuroimaging procedures by means of selected examples.MethodsMultimodal imaging data of exemplary patients who underwent FDG, Amyloid and AV-1451-PET, FP-CIT-SPECT and MRI imaging in the routine clinical workup in our department is presented and the currently available literature on the topic of imaging in neurodegenerative diseases was reviewed.ResultsThe complementary value of the applied imaging methods is demonstrated in pairs of representative cases. Depending on the clinical question, individual methods or a meaningful multimodal combination is required to achieve optimal diagnostic benefit.
000844289 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000844289 588__ $$aDataset connected to CrossRef
000844289 7001_ $$0P:(DE-Juel1)166265$$aBischof, Gérard N.$$b1
000844289 7001_ $$0P:(DE-HGF)0$$aDrzezga, Alexander$$b2
000844289 773__ $$0PERI:(DE-600)2712000-4$$a10.1007/s40336-017-0242-y$$gVol. 5, no. 5, p. 465 - 471$$n5$$p465 - 471$$tClinical and translational imaging$$v5$$x2281-7565$$y2017
000844289 8564_ $$uhttps://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.pdf$$yRestricted
000844289 8564_ $$uhttps://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.gif?subformat=icon$$xicon$$yRestricted
000844289 8564_ $$uhttps://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000844289 8564_ $$uhttps://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.jpg?subformat=icon-180$$xicon-180$$yRestricted
000844289 8564_ $$uhttps://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.jpg?subformat=icon-640$$xicon-640$$yRestricted
000844289 8564_ $$uhttps://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.pdf?subformat=pdfa$$xpdfa$$yRestricted
000844289 909CO $$ooai:juser.fz-juelich.de:844289$$pVDB
000844289 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000844289 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000844289 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aClarivate Analytics Master Journal List
000844289 9141_ $$y2018
000844289 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166265$$aForschungszentrum Jülich$$b1$$kFZJ
000844289 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000844289 920__ $$lyes
000844289 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000844289 980__ $$ajournal
000844289 980__ $$aVDB
000844289 980__ $$aI:(DE-Juel1)INM-3-20090406
000844289 980__ $$aUNRESTRICTED